MEDISAFE 1 TECHNOLOGIES CORP: 10-Q/A filed 2012-09-06

Name: MEDISAFE 1 TECHNOLOGIES CORP: 10-Q/A filed 2012-09-06
Creator: MEDISAFE 1 TECHNOLOGIES CORP
License: https://creativecommons.org/licenses/by/4.0/

What MEDISAFE 1 TECHNOLOGIES CORP reported in its quarterly report amendment filed 2012-09-06 (fiscal Q2 2012): 16 published measures, 46 facts as tagged in accession 0001144204-12-049775.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-Q/A (quarterly report amendment)
Filed: 2012-09-06
Fiscal period: fiscal Q2 2012
Accession: 0001144204-12-049775 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MEDISAFE 1 TECHNOLOGIES CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-06-30	202,839	USD
At 2011-12-31	528	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-06-30	66,207	USD
At 2011-12-31	123,598	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2012-06-30	136,631	USD
At 2011-12-31	-123,070	USD
At 2010-12-31	653	USD
At 2009-12-31	-121,514	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-06-30	24	USD
At 2011-12-31	528	USD
At 2010-12-31	56,155	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-03-30 to 2012-06-30	-151,540	USD	93
2012-01-01 to 2012-06-30	-299,868	USD	182
2009-07-16 to 2012-06-30	-2,030,503	USD	1081
2011-01-01 to 2011-12-31	-1,343,786	USD	365
2011-04-01 to 2011-06-30	-599,402	USD	91
2011-01-01 to 2011-06-30	-776,591	USD	181
2010-01-01 to 2010-12-31	-264,735	USD	365
2009-07-16 to 2009-12-31	-122,114	USD	169

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-27,693	USD	182
2009-07-16 to 2012-06-30	-317,874	USD	1081
2011-01-01 to 2011-06-30	-139,352	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	46,254	USD	182
2009-07-16 to 2012-06-30	336,963	USD	1081
2011-01-01 to 2011-06-30	83,197	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-19,065	USD	182
2009-07-16 to 2012-06-30	-19,065	USD	1081

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	87,500	USD	182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-03-30 to 2012-06-30	-104,869	USD	93
2012-01-01 to 2012-06-30	-208,943	USD	182
2009-07-16 to 2012-06-30	-1,749,756	USD	1081
2011-04-01 to 2011-06-30	-542,243	USD	91
2011-01-01 to 2011-06-30	-701,588	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-06-30	192,839	USD
At 2011-12-31	528	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-06-30	66,207	USD
At 2011-12-31	123,598	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	28,653	USD	182
2009-07-16 to 2012-06-30	28,653	USD	1081

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2009-07-16 to 2012-06-30	123,133	USD	1081
2011-01-01 to 2011-06-30	3,000	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-06-30	325,864,945	shares
At 2011-12-31	91,903,319	shares

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	40,000	USD	182
2009-07-16 to 2012-06-30	165,116	USD	1081
2009-07-16 to 2009-12-31	600	USD	169

Inspect the source

Entity: MEDISAFE 1 TECHNOLOGIES CORP / CIK 0001471487
Captured: 2026-09-23 02:51 UTC
SEC response SHA-256: c04afc22958039996c393cd09c77eafb0e8e55dea80d114ec407f98c324d6141

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001471487.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))